Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,947 | -8,068 | -19,773 | -13,516 | -8,641 |
| Accounts receivable | N/A | -72 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -373 | 237 | 472 | 64 | 385 |
| Other Working Capital | -1,452 | -62 | 3,086 | 2,169 | 1,198 |
| Other Operating Activity | 10,500 | 4,378 | 3,144 | 2,204 | 1,136 |
| Operating Cash Flow | $-8,272 | $-3,587 | $-13,071 | $-9,079 | $-5,921 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,302 | 4,994 | 11,418 | 5,751 | 5,750 |
| Other Financing Activity | -597 | -277 | -2,148 | -1,506 | -1,630 |
| Financing Cash Flow | $12,704 | $4,717 | $9,271 | $4,246 | $4,120 |
| Exchange Rate Effect | -4 | -10 | 0 | -13 | -3 |
| Beginning Cash Position | 7,151 | 7,151 | 10,951 | 10,951 | 10,951 |
| End Cash Position | 11,579 | 8,271 | 7,151 | 6,105 | 9,146 |
| Net Cash Flow | $4,429 | $1,121 | $-3,800 | $-4,846 | $-1,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,272 | -3,587 | -13,071 | -9,079 | -5,921 |
| Free Cash Flow | -8,272 | -3,587 | -13,071 | -9,079 | -5,921 |